Super-spreaders during SARS-CoV-2 pandemic in Cartagena, Colombia
DOI:
https://doi.org/10.17533/udea.iatreia.128Keywords:
communicable period, coronavirus infections, pandemics, social isolationAbstract
Introduction: The dissemination of infectious agents in a population can occur both in a homogeneous or heterogeneous way. SARS-CoV-2 has heterogeneous transmission by superspreaders (SS) (people with certain characteristics that transmit the infection to 80% of the exposed population).
Objective: To describe the characteristics of SS in the first cases of COVID-19 in Cartagena, Colombia.
Methodology: Epidemiological surveillance study carried out in Cartagena from February 25 to April 20, 2020, by the infection committee of Clínica Gestión Salud and the administrative department of health,
on suspected cases, confirmed by RT-PCR for SARSCoV-2, and close contacts of those confirmed cases for coronavirus infection.
Results: In 30 days, two SS patients were confirmed, 21 secondary cases (10 and 11, each one), and two tertiary cases. The 1st SS began symptoms 48 hours after exposure, he was hospitalized on the 7th day after
symptoms began and died 72 hours after hospitalization. The 2nd SS hospitalized for diabetic ketoacidosis, with subsequent finding of anosmia and dysgeusia, remained in the ICU one month. Of the secondary cases, 9.5% (2/21) were hospitalized in the ICU, 47% (10/21) in the general ward and 42% (9/21) were quarantined.
Sixty one percent (14/23) of those infected were from health personnel.
Conclusions: SS are important in the dynamics of transmission infectious diseases. Failure to identify or misdiagnosis a patient with COVID-19, together with hospital transfer, are the main causes of the generation of a disproportionate number of secondary cases.
Downloads
References
(1) Xiaolu Tang, Changcheng Wu, Xiang Li, Yuhe Song, Yao X, Xinkai Wu, et al. On the origin and continuing evolution of SARS-CoV-2. Natl Sci Rev. 2020;7(6):1012-23. DOI 10.1093/nsr/nwaa036.
(2) Rodríguez DJ, Torres-Sorando L. Models of infectious diseases in spatially heterogeneous environments. Bull Math Biol. 2001 May;63(3):547-71. DOI 10.1006/bulm.2001.0231.
(3) Woolhouse ME, Dye C, Etard JF, Smith T, Charlwood JD, Garnett GP, et al. Heterogeneities in the transmission of infectious agents: implications for the design of control programs. Proc Natl Acad Sci U S A. 1997 Jan 7;94(1):338-42. DOI 10.1073/pnas.94.1.338.
(4) Kumar S, Jha S, Rai SK. Significance of super spreaders events in COVID-19. Indian J Public Health. 2020;64:S139-41. DOI 10.4103/ijph.IJPH_495_20.
(5) Beldomenico PM. Do superspreaders generate new superspreaders? A hypothesis to explain the propagation pattern of COVID-19. Int J Infect Dis. 2020 Jul;96:461–3. DOI 10.1016/j.ijid.2020.05.025.
(6) Stein RA. Super-spreaders in infectious diseases. Int J Infect Dis. 2011 Aug;15(8):e510–3. DOI 10.1016/j.ijid.2010.06.020.
(7) Brooks J. The sad and tragic life of Typhoid Mary. CMAJ. 1996 Mar 15;154(6):915–6.
(8) Paunio M, Peltola H, Valle M, Davidkin I, Virtanen M, Heinonen OP. Explosive school-based measles outbreak: intense exposure may have resulted in high risk, even among revaccinees. Am J Epidemiol. 1998 Dec 1;148(11):1103–10. DOI 10.1093/oxfordjournals.aje.a009588.
(9) Curtis AB, Ridzon R, Vogel R, McDonough S, Hargreaves J, Ferry J, et al. Extensive transmission of Mycobacterium tuberculosis from a child. N Engl J Med. 1999 Nov 11;341(20):1491–5. DOI 10.1056/NEJM199911113412002.
(10) Khan AS, Tshioko FK, Heymann DL, Le Guenno B, Nabeth P, Kerstiëns B, et al. The reemergence of ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. J Infect Dis. 1999 Feb;179(s1):S76–86. DOI 10.1086/514306.
(11) Li Y, Yu IT, Xu P, Lee JH, Wong TW, Ooi PL, et al. Predicting super spreading events during the 2003 severe acute respiratory syndrome epidemics in Hong Kong and Singapore. Am J Epidemiol. 2004 Oct 15;160(8):719-28. DOI 10.1093/aje/kwh273.
(12) Tomlinson B, Cockram C. SARS: experience at Prince of Wales Hospital, Hong Kong. The Lancet. 2003 May;361(9368):1486–7.
(13) Riley S, Fraser C, Donnelly CA, Ghani AC, Abu-Raddad LJ, Hedley AJ, et al. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science. 2003 Jun 20;300(5627):1961-6. DOI 10.1126/science.1086478.
(14) Wong G, Liu W, Liu Y, Zhou B, Bi Y, Gao GF. MERS, SARS, and Ebola: The Role of super-spreaders in infectious disease. Cell Host Microbe. 2015 Oct 14;18(4):398-401. DOI 10.1016/j.chom.2015.09.013.
(15) Cowling BJ, Park M, Fang VJ, Wu P, Leung GM, Wu JT. Preliminary epidemiological assessment of MERSCoV outbreak in South Korea, May to June 2015. Euro Surveill. 2015 Jun 25;20(25):7-13. DOI 10.2807/1560-7917.es2015.20.25.21163.
(16) Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM. Superspreading and the effect of individual variation on disease emergence. Nature. 2005 Nov;438(7066):355–9. DOI 10.1038/nature04153.
(17) Colombia. Ministerio de salud y protección social. Lineamientos para la detección y manejo de casos de COVID-19 por los prestadores de servicios de salud en Colombia [internet]. [Consultado febrero 2021]. Disponible: https://cutt.ly/RmO4ggV
(18) Gil Cuesta J, Vaqué Rafart J. Aspectos básicos de la transmisibilidad. Vacunas. 2008 Jan;9(1):25–33. DOI 10.1016/S1576-9887(08)71918-6.
(19) Colombia. Ministerio de Salud y protección social. Colombia confirma primera muerte por coronavirus. Boletín de prensa N 086 de 2020 [internet]. [Consultado febrero 2021]. Disponible: https://cutt.ly/7mO4IFD
(20) Speth MM, Singer-Cornelius T, Oberle M, Gengler I, Brockmeier SJ, Sedaghat AR. Olfactory dysfunction and sinonasal symptomatology in COVID-19: prevalence, severity, timing, and associated characteristics. Otolaryngol Head Neck Surg. 2020 Jul;163(1):114-20. DOI 10.1177/0194599820929185.
(21) Liu J, Liao X, Qian S, Yuan J, Wang F, Liu Y, et al. Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen, China, 2020. Emerg Infect Dis. 2020 Jun;26(6):1320-1323. DOI 10.3201/eid2606.200239.
(22) Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-toperson transmission: a study of a family cluster. The Lancet. 2020 Feb;395(10223):514–23. DOI 10.1016/S0140-6736(20)30154-9.
(23) Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med. 2020 Mar 26;382(13):1199–207.
(24) Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY, Marimuthu K. Air, Surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) from a symptomatic patient. JAMA. 2020 Apr 28;323(16):1610-1612. DOI 10.1001/jama.2020.3227.
(25) Shen Z, Ning F, Zhou W, He X, Lin C, Chin DP, et al. Superspreading SARS events, Beijing, 2003. Emerg Infect Dis. 2004 Feb;10(2):256-60. DOI 10.3201/eid1002.030732.
(26) Park D, Huh HJ, Kim YJ, Son DS, Jeon HJ, et al. Analysis of intrapatient heterogeneity uncovers the microevolution of Middle East respiratory syndrome coronavirus. Cold Spring Harb Mol Case Stud. 2016 Nov;2(6):a001214. DOI 10.1101/mcs.a001214.
(27) Kim Y, Ryu H, Lee S. Agent-Based Modeling for Super-Spreading Events: A Case Study of MERS-CoV Transmission Dynamics in the Republic of Korea. Int J Environ Res Public Health.2018 Oct 26;15(11):2369. DOI 10.3390/ijerph15112369.
(28) Baker MG, Wilson N, Anglemyer A. Successful elimination of Covid-19 transmission in New Zealand. N Engl J Med. 2020 Aug 20;383(8):e56. DOI 10.1056/NEJMc2025203.
(29) Park YJ, Choe YJ, Park O, Park SY, Kim YM, Kim J. Contact tracing during coronavirus disease outbreak, South Korea, 2020. Emerg Infect Dis. 2020 Oct;26(10):2465-8. DOI 10.3201/eid2610.201315.
(30) World Health Organization. Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected [internet]. [Consultado agosto 2020]. Disponible: https://cutt.ly/4mO7egR
(31) Wang X, Zhou Q, He Y, Liu L, Ma X, Wei X, et al. Nosocomial outbreak of COVID-19 pneumonia in Wuhan, China. Eur Respir J. 2020 Jun;55(6):2000544. DOI 10.1183/13993003.00544-2020.
(32) Taylor J, Rangaiah J, Narasimhan S, Clark J, Alexander Z, Manuel R, et al. Nosocomial COVID-19: experience from a large acute NHS Trust in South-West London. J Hosp Infect. 2020 Nov;106(3):621–5. DOI 10.1016/j.jhin.2020.08.018.
(33) Rhee C, Baker M, Vaidya V, Tucker R, Resnick A, Morris CA, et al. Incidence of nosocomial COVID-19 in patients hospitalized at a large US academic medical center. JAMA Netw Open. 2020 Sep 9;3(9):e2020498. DOI 10.1001/jamanetworkopen.2020.20498.
(34) Sneppen K, Simonsen L. Impact of Superspreaders on dissemination and mitigation of COVID-19. MedRxiv. 2020. DOI 10.1101/2020.05.17.20104745.
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Universidad de Antioquia

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Papers published in the journal are available for use under the Creative Commons license, specifically Attribution-NonCommercial-ShareAlike 4.0 International.
The papers must be unpublished and sent exclusively to the Journal Iatreia; the author uploading the contribution is required to submit two fully completed formats: article submission and authorship responsibility.